H200s in China, Apple Blocks Vibe Coding, Peptide Debates | Andy Fang, Matt Jayson, Dr. Cameron Sepah, Chris Gadek, Chris Hladczuk, Georgios Konstantopoulos, Matt Huang
🤖 AI Summary
Overview
This episode dives into a range of topics, from NVIDIA's H200 chip sales in China and Apple's crackdown on vibe coding apps to the evolving landscape of private credit in the AI era. Guests include leaders from DoorDash, Multiply, Maximus, AdQuick, Hanover Park, and Tempo, who discuss innovations in AI, advertising, health optimization, and financial infrastructure.
Notable Quotes
- If someone's building DoorDash today, it would not look like DoorDash.
– Andy Fang, on reimagining the platform with AI-driven agentic commerce.
- We built the world's most insatiable AI agents.
– Matt Jayson, on Multiply's approach to self-learning ads.
- We don't have a healthcare system; we have a sick care system.
– Dr. Cameron Sepah, on the need for proactive performance medicine.
🖥️ NVIDIA’s H200 Chips and the China Market
- NVIDIA announced the resumption of H200 chip sales to China, signaling a shift in U.S.-China tech relations.
- The CHIPS Act initially banned chip exports to China, but NVIDIA's new licensing agreements allow limited sales, potentially worth billions annually.
- The geopolitical implications of chip sales were discussed, including risks tied to Taiwan's TSMC and the global chip shortage.
🍎 Apple’s Crackdown on Vibe Coding Apps
- Apple has restricted updates to vibe coding apps like Replit and VibeCode, citing App Store rules against apps running unapproved code.
- Developers argue these apps empower users to create web and mobile applications, challenging Apple's control over app distribution.
- The move highlights tensions between innovation in coding tools and platform gatekeeping.
💊 The Peptide Debate and Performance Medicine
- Dr. Cameron Sepah of Maximus discussed the rise of performance medicine, focusing on FDA-approved treatments like testosterone, GLP-1 agonists, and growth hormone peptides.
- He emphasized the importance of personalized medicine, advocating for tailored protocols to optimize health and performance.
- Concerns about unregulated peptides like BPC-157 were raised, with Dr. Sepah urging caution and reliance on FDA-approved options.
📊 Private Credit Meets AI Disruption
- The private credit market, valued at $3 trillion, faces challenges as AI disrupts traditional software companies.
- Eric Souffert argued that while defaults may rise in software-heavy portfolios, AI-driven productivity gains could offset losses.
- The discussion highlighted the need for private credit firms to adapt to AI's transformative impact on business models.
🚀 AI and Agentic Commerce at DoorDash
- Andy Fang, co-founder of DoorDash, detailed the company’s acquisition of Metis, an AI research lab, to enhance agentic commerce.
- AI is being used to address customer decision paralysis and help restaurants optimize pricing and promotions.
- Fang emphasized the importance of seamless AI integration, avoiding overt branding while delivering tangible benefits.
AI-generated content may not be accurate or complete and should not be relied upon as a sole source of truth.
📋 Episode Description
Sign up for TBPN’s daily newsletter at TBPN.com
- (05:54) - H200s Are Going to China
- (18:27) - 𝕏 Timeline Reactions
- (27:33) - Apple Cracks Down on Vibe Coding Apps
- (37:36) - Peptide Debate
- (46:17) - 𝕏 Timeline Reactions
- (54:50) - Private Credit Meets the AI Shift
- (01:05:44) - Andy Fang, co-founder and head of consumer engineering at DoorDash, discusses the company's recent acquisition of Metis, an applied AI research lab, to enhance AI integration into their services. He highlights the potential of AI to improve customer experiences by addressing decision paralysis through agentic commerce, and to assist restaurants in optimizing operations, such as pricing and promotions. Fang also emphasizes the importance of creating seamless, beneficial AI-driven experiences without overtly branding them as AI features.
- (01:25:05) - Matt Jayson, founder and CEO of Multiply, discusses his company's innovative approach as the first hybrid AI media agency, combining AI agents with human expertise to create self-learning ads that adapt based on customer feedback. He highlights their recent emergence from stealth mode with a $9.5 million funding round and emphasizes the need for modernized advertising strategies in the B2B sector, noting that traditional ads become stale quickly. By integrating AI with human media buying, Multiply aims to revolutionize advertising effectiveness and efficiency.
- (01:34:12) - Dr. Cameron Sepah, a licensed clinical psychologist and former assistant clinical professor of psychiatry at UCSF School of Medicine, is the founder and CEO of Maximus, a company specializing in men's health and hormone optimization. In the conversation, he discusses the concept of performance medicine, emphasizing the use of FDA-approved treatments like testosterone, GLP-1 agonists, and growth hormone peptides to enhance health and performance. Dr. Sepah also highlights the importance of personalized medicine, advocating for tailored protocols that address individual health needs beyond traditional healthcare models.
- (02:06:19) - Chris Gadek, CEO of AdQuick, discusses how the company is revolutionizing out-of-home (OOH) advertising by integrating technology to streamline planning, buying, and measurement processes. He highlights AdQuick's recent partnership with OUTFRONT Media, a major player in the OOH space, to enhance campaign execution and measurement across various formats. Gadek also emphasizes the importance of proving the effectiveness of OOH advertising through advanced analytics and measurement tools.
- (02:17:05) - Chris Hladczuk, co-founder and CEO of Hanover Park, an AI-native fund administration platform, discusses how his company streamlines financial operations for investment firms by replacing manual processes—referred to as "human duct tape"—with AI-driven solutions. He highlights the platform's ability to provide rea